Prucalopride, a serotonin-4 receptor agonist, is indicated for the treatment of chronic idiopathic constipation in adults. The first generic version of Motegrity ® has been approved by the Food and ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The U.S. Court of Appeals for the Federal Circuit ordered MSN not to launch its drug, opens new tab while it considers Novartis' request for a longer ban on the generic version. The decision marks ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...

The first generic version of Motegrity ® has been approved by the Food and Drug Administration and is now available from ANI Pharmaceuticals. Prucalopride, a serotonin-4 receptor agonist ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®.

WASHINGTON -Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis (SIX ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

It did not provide any details about the launch or pricing for its drug. Hikma's generic drug was tentatively approved in June by the FDA. Diabetes drug Victoza, or liraglutide, is a first ...